Article and Video CATEGORIES

Cancer Journey

Search By

Dr. Jack West is a medical oncologist and thoracic oncology specialist who is the Founder and previously served as President & CEO, currently a member of the Board of Directors of the Global Resource for Advancing Cancer Education (GRACE)

 

Our Next Webinar: Dr. Dara Aisner on Molecular Pathology in Lung Cancer
Author
Howard (Jack) West, MD

Folks here know that just about every day we discuss questions of what molecular marker test to order for lung cancer, how important it is, how it's done, what tissue is needed, and other very timely and practical issues in lung cancer.  These are questions that evolve every few months, as new research emerges with different markers.  

Who is doing this work? People like Dr. Dara Aisner, Co-Director of the Colorado Molecular Correlates Laboratory and Assistant Professor in the Department of Pathology at the University of Colorado.  Yes, that's the same University of Colorado lab that we're always talking about here as representing the absolute leading edge of molecular oncology, one of the very first labs on the planet to do ALK testing and now ROS1 testing, and among the most integral participants in the Lung Cancer Molecular Consortium.  

We're lucky enough to have Dr. Aisner join me on Wednesday, August 22nd at 7 PM Eastern/4 PM Pacific to discuss a broad range of important issues in pathology and molecular diagnostics, ranging from how we get from a biopsy to a marker result, what the current limitations are, how to overcome those barriers, and what the emerging future of molecular oncology looks like.  Sounds very interesting, right?

So join us for this program, co-sponsored with LUNGevity Foundation.  We'll have the audio and video versions of the webinar online, along with the transcript and figures, but you'll want to be there for the live program, with time for your own questions, if you can.  You can also feel free to get a jump on things by suggesting some questions here as a comment.

 Just click here for free registration. I think this webinar will be of great interest to lots of you.

 

Next Previous link

Previous PostNext Post

Related Content

Article
The journey to conquer lung cancer is paved with scientific discovery, and the identification of the EGFR and ALK genes as crucial players marks a significant milestone. Unraveling how mutations in these seemingly small segments of our DNA can unleash the destructive force of cancer has opened up exciting new therapeutic avenues. This exploration delves into the cutting-edge world of EGFR and ALK-targeted therapies, highlighting the progress made and the ongoing quest for even more effective and personalized strategies to combat this formidable disease.
Image
Rare cancers
Video
In these videos,  Dr. Jared Weiss gives a brief overview of NUT Carcinoma, discusses treatment options and possible future treatment.  To watch the complete playlist, click here.  
Article
Don't let the word "small" deceive you. Small cell lung cancer (SCLC) casts a long shadow, impacting lives with its aggressive nature and the complexities of its treatment. But while the challenges are real, so is the progress. Breakthroughs in small cell lung cancer treatment offer hope. Immunotherapy plus chemo-radiation improves survival by 22 months. Screening catches it early.

Forum Discussions

Can SCLC also be treated with targeted therapy?

Hi amitchouhan,

Welcome to Grace. At this time, there aren't any targeted therapies to treat SCLC, but there are new treatments. Check out our latest OncTalk webinar from December. The last...

I was searching for this, Thank you so much for the info.

Recent Comments

JOIN THE CONVERSATION
Yes, it's crucial to discuss…
By JanineT GRACE … on
Definitely a good idea to…
By OakleeFarnick on
Thank you for sharing
By LeviDrake on
Hi bluesun,I don't know of…
By JanineT GRACE … on